AVCT Avacta Group Plc

TIDMAVCT

RNS Number : 5404J

Avacta Group PLC

08 April 2015

Avacta Group plc

("Avacta" or "the Group")

Notice of Results

Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare will be reporting its interim results for the six months ended 31 January 2015 on Tuesday 28 April 2015.

Alastair Smith, CEO and Tim Sykes, FD will be hosting a briefing for analysts on Tuesday 28 April 2015 at 9.30am at the London Capital Club, 15 Abchurch Lane, London, EC4N 7BW.

For more information or to register to attend the briefing contact Walbrook PR (contact details below).

Enquiries:

 
 Avacta Group plc                      Tel: +44 (0) 
  Alastair Smith, Chief Executive       844 414 0452 
  Officer                               www.avacta.com 
  Tim Sykes, Chief Financial Officer 
 Numis Securities Limited              Tel: +44 (0) 
  Michael Meade / Freddie Barnfield     207 260 1000 
  - Nominated Adviser                   www.numiscorp.com 
  James Black - Corporate Broking 
 Media Enquiries                       Tel: +44 (0) 
  Walbrook PR Ltd                       207 933 8780 
  Mike Wort / Anna Dunphy               avacta@walbrookpr.com 
 
 
 
  About Avacta Group 
  plc - www.avacta.com 
  Avacta Group plc 
  is a global provider 
  of innovative 
  technologies, 
  consumables and 
  reagents for the 
  life science markets, 
  from drug discovery 
  to diagnostics. 
  Avacta operates 
  through three 
  divisions: Avacta Life Sciences                     Novel engineered antibody replacements 
    www.avactalifesciences.com               called Affimers, with a wide 
                                             range of Life Science applications 
                                             in diagnostics, drug and biomarker 
                                             discover and biotech research 
                                             and development. 
  ---------------------------------------  --------------------------------------- 
              Avacta Animal                 Veterinary diagnostics reference 
               Health                        laboratory and diagnostic kit 
               www.avactaanimalhealth.com    provider. 
  ---------------------------------------  --------------------------------------- 
   Avacta Analytical                        High throughput analysis instrument, 
    www.avactaanalytical.com                 Optim, to help reduce the cost 
                                             and risk of drug development. 
  ---------------------------------------  --------------------------------------- 
 
 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORSSFFIWFISEIL

Avacta (LSE:AVCT)
Historical Stock Chart
From Mar 2024 to Apr 2024

Avacta (LSE:AVCT)
Historical Stock Chart
From Apr 2023 to Apr 2024